Cagrilintide

Synonyms: Cagrilintide, 1415456-99-3, Amylin analog, Long-acting amylin analog, NN-9935, Cagrilintide acetate

Cagrilintide is a synthetic analog of human amylin, a peptide hormone that works alongside insulin to regulate postprandial glucose levels and signal satiety. Developed by Novo Nordisk, this long-acting amylin analog is designed for once-weekly dosing, making it a promising candidate for obesity and type 2 diabetes management. Its extended half-life is achieved through fatty acid acylation, which promotes albumin binding and slows renal clearance.

機能

• Amylin receptor agonist: Activates amylin receptors, reducing food intake and delaying gastric emptying.
• Appetite regulation: Enhances satiety signaling, leading to reduced caloric intake.
• 体重管理: Promotes weight loss in overweight and obese individuals.
• Glycemic control: Helps regulate postprandial glucose levels.

出典および標準化

• 出典: Synthetic peptide, produced via solid-phase peptide synthesis.
• 標準化: Purity ≥98% (HPLC), peptide content 70-90%.
• フォーム: Lyophilized powder, acetate salt.
• 用途: Research on obesity, type 2 diabetes, and metabolic disorders.

資料・供給

• 最小発注数量（MOQ）: 5g
• 月間処理能力: 1 kg
• リードタイム: 5-10 days after order
• ドキュメント: COA、MSDS、TDS
• パッケージ: Sealed vials or custom packaging

見積依頼

• 当社の住所: 中国陝西省西安市メインストリート280番地
• リブバイオ株式会社. — メールアドレス： info@lyvbio.com